BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2649129)

  • 1. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas.
    López-Nevot MA; Esteban F; Ferrón A; Gutiérrez J; Oliva MR; Romero C; Huelin C; Ruiz-Cabello F; Garrido F
    Br J Cancer; 1989 Feb; 59(2):221-6. PubMed ID: 2649129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class I and II antigens on gastric carcinomas and autologous mucosa.
    Ferron A; Perez-Ayala M; Concha A; Cabrera T; Redondo M; Oliva MR; Ruiz-Cabello F; Garrido F
    J Immunogenet; 1989; 16(4-5):413-23. PubMed ID: 2639912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
    Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
    Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].
    Esteban F; Concha A; Ruiz-Cabello F; Garrido F
    Acta Otorrinolaringol Esp; 1990; 41(5):297-303. PubMed ID: 2076309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
    Cabrera T; Salinero J; Fernandez MA; Garrido A; Esquivias J; Garrido F
    Hum Immunol; 2000 May; 61(5):499-506. PubMed ID: 10773352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
    Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
    Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers.
    de Miranda NF; Nielsen M; Pereira D; van Puijenbroek M; Vasen HF; Hes FJ; van Wezel T; Morreau H
    J Pathol; 2009 Sep; 219(1):69-76. PubMed ID: 19462419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.
    Ruiz-Cabello F; Lopez Nevot MA; Gutierrez J; Oliva MR; Romero C; Ferron A; Esteban F; Huelin C; Piris MA; Rivas C
    Clin Exp Metastasis; 1989; 7(2):213-26. PubMed ID: 2493352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].
    Esteban F; Concha A; Delgado M; Ruiz-Cabello F; Garrido F
    Acta Otorrinolaringol Esp; 1990; 41(6):359-68. PubMed ID: 2092725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.
    Goepel JR; Rees RC; Rogers K; Stoddard CJ; Thomas WE; Shepherd L
    Br J Cancer; 1991 Nov; 64(5):880-3. PubMed ID: 1718386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
    Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
    Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
    Esteban F; Concha A; Delgado M; Pérez-Ayala M; Ruiz-Cabello F; Garrido F
    Br J Cancer; 1990 Dec; 62(6):1047-51. PubMed ID: 2257212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours.
    Middleton D; Vilchez JR; Cabrera T; Meenagh A; Williams F; Halfpenny I; Maleno I; Ruiz-Cabello F; Lopez-Nevot MA; Garrido F
    Tissue Antigens; 2007 Mar; 69(3):220-6. PubMed ID: 17493145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
    van den Ingh HF; Ruiter DJ; Griffioen G; van Muijen GN; Ferrone S
    Br J Cancer; 1987 Feb; 55(2):125-30. PubMed ID: 3028461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
    Ramal LM; Maleno I; Cabrera T; Collado A; Ferron A; Lopez-Nevot MA; Garrido F
    Hum Immunol; 2000 Oct; 61(10):1001-12. PubMed ID: 11082513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
    Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
    Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class I antigens and tumour-infiltrating leucocytes in laryngeal cancer: long-term follow-up.
    Esteban F; Redondo M; Delgado M; Garrido F; Ruiz-Cabello F
    Br J Cancer; 1996 Dec; 74(11):1801-4. PubMed ID: 8956796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
    Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
    Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.
    Stein B; Momburg F; Schwarz V; Schlag P; Moldenhauer G; Möller P
    Br J Cancer; 1988 Apr; 57(4):364-8. PubMed ID: 2839218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.